What is Alvinol used for?

Alvinol is indicated for Insomnia, Severe Insomnia.

Alvinol is developed by AbbVie.

What development phase is Alvinol in?

Alvinol is FDA-approved (marketed).

What is the generic name of Alvinol?

ETHCHLORVYNOL is the generic (nonproprietary) name of Alvinol.

Last reviewed 2026-04-20 · How we verify

Alvinol (ETHCHLORVYNOL)

AbbVie · FDA-approved approved Small molecule Quality 21/100

ETHCHLORVYNOL (Alvinol), marketed by AbbVie, is a GABA-enhancing insomnia treatment with a key composition patent expiring in 2028. Its mechanism of action provides a strong therapeutic effect for inducing sleep, positioning it competitively against off-patent alternatives like scopolamine and propiomazine. The primary risk is the increasing availability of generic competitors and the strong patent protection of newer drugs like dexmedetomidine and suvorexant, which could erode market share.

At a glance

Generic name	ETHCHLORVYNOL
Sponsor	AbbVie
Drug class	ethchlorvynol
Target	GABA-A receptor alpha-1/beta-3/gamma-2
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1961

Approved indications

Insomnia
Severe Insomnia

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions